Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionCapital Fund Management S.a.
Latest Disclosed Ownership149,631 shares
Latest Disclosed Value $ 19,712,387
Capital Fund Management S.a. ownership in NBIX / Neurocrine Biosciences, Inc.

On May 14, 2026 - Capital Fund Management S.a. filed a 13F-HR form disclosing ownership of 149,631 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $19,712,387 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 80,125 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 86.75% during the quarter.

Capital Fund Management S.a. has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NEUROCRINE BIOSCIENCES INC COM NEUROCRINE BIOSCIENCES INC COM 64125C109 149,631 69,506 86.75 19,712 73.46 0.0891
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES INC COM NEUROCRINE BIOSCIENCES INC COM 64125C109 80,125 -43,579 -35.23 11,364 -34.56 0.0316
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 123,704 -79,924 -39.25 17,366 -32.15 0.0455
2025-08-13 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 203,628 27,987 15.93 25,594 31.76 0.0705
2025-05-14 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 175,641 71,117 68.04 19,426 36.15 0.0560
2025-02-13 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 104,524 -7,048 -6.32 14,268 10.98 0.0364
2024-11-13 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 111,572 54,621 95.91 12,855 63.97 0.0352
2024-08-13 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 56,951 56,951 7,840 0.0231
2021-08-12 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -60,266 -100.00 0 -100.00
2021-05-14 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 60,266 40,409 203.50 5,861 207.93 0.0647
2021-02-12 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,857 -2,810 -12.40 1,903 -12.67 0.0179
2020-11-13 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 22,667 3,329 17.21 2,180 -7.63 0.0269
2020-08-13 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,338 -4,305 -18.21 2,359 15.30 0.0374
2020-05-13 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,643 23,643 2,046 0.0317
2019-11-13 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -6,932 -100.00 0 -100.00
2019-08-12 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,932 3,612 108.80 585 100.34 0.0053
2019-05-13 2019-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 3,320 -21,712 -86.74 292 -83.67 0.0026
2019-05-13 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 25,032 0 1,788
2019-02-13 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 25,032 13,732 121.52 1,788 28.73 0.0158
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,300 11,300 1,389 0.0076
2017-08-10 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -146,598 -100.00 0 -100.00
2017-05-03 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 146,598 117,886 410.58 6,348 471.38 0.0529
2017-02-08 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 28,712 15,760 121.68 1,111 69.36 0.0096
2016-10-31 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,952 -64,169 -83.21 656 -81.28 0.0060
2016-07-27 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 77,121 68,711 817.02 3,505 952.55 0.0328
2016-05-02 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,410 -84,126 -90.91 333 -93.64 0.0032
2016-01-28 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 92,536 -217,173 -70.12 5,235 -57.52 0.0539
2015-10-27 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 309,709 238,342 333.97 12,323 261.59 0.1378
2015-07-28 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 71,367 71,367 3,408 0.0432
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-08-13 2020-06-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-13 2020-03-31 13F NEUROCRINE BIOSCIENCES COM Call 7,600 -50.33 658 -60.00 n/a n/a n/a
2020-02-13 2019-12-31 13F NEUROCRINE BIOSCIENCES COM Call 15,300 1,645 n/a n/a n/a
2019-08-12 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-13 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Call 8,300 0.00 593 0.00 n/a n/a n/a
2019-02-13 2018-12-31 13F NEUROCRINE BIOSCIENCES COM Call 8,300 -78.99 593 -87.79 n/a n/a n/a
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM Call 39,500 4,857 n/a n/a n/a
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES COM Call 59,200 4,909 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-08-12 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-13 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Put 18,100 0.00 1,293 0.00 n/a n/a n/a
2019-02-13 2018-12-31 13F NEUROCRINE BIOSCIENCES COM Put 18,100 -53.59 1,293 -73.03 n/a n/a n/a
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM Put 39,000 4,795 n/a n/a n/a
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES COM Put 78,200 6,485 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.